Envoy Medical COCH Fair Value Adjustment Of Warrants
Fair Value Adjustment Of Warrants at other companies
Other financials
Where this comes from
Reported directly by Envoy Medical in its filing.
Tagged under the XBRL concept us-gaap:FairValueAdjustmentOfWarrants.
The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Envoy Medical's fair value adjustment of warrants.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Envoy Medical's fair value adjustment of warrants?
- Envoy Medical (COCH) reported fair value adjustment of warrants of $13K in Q1 2026.
- How has Envoy Medical's fair value adjustment of warrants changed year-over-year?
- Envoy Medical's fair value adjustment of warrants increased by 103.1% year-over-year, from -$421K to $13K.
- What is the long-term trend for Envoy Medical's fair value adjustment of warrants?
- Over 2 years (2022 to 2025), Envoy Medical's fair value adjustment of warrants has grown at a -88.3% compound annual growth rate (CAGR), from -$39.22M to -$534K.
- What does fair value adjustment of warrants mean?
- Captures the periodic change in the estimated fair value of outstanding warrant liabilities. As these instruments are often sensitive to stock price volatility, this adjustment reflects the non-cash impact of market valuation shifts on the balance sheet.